The synovial expression and serum levels of interleukin-6, interleukin- 11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 40, Issue 6, 1997, Pages 1096-1105

  Okamoto, Hideyuki ^a   Yamamura, Masahiro ^a   Morita, Yoshitaka ^a   Harada, Seishi ^a   Makino, Hirofumi ^a   Ota, Zensuke ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 11; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M;

ACUTE PHASE RESPONSE; ARTICLE; CELL ISOLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MEDIATOR RELEASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-11; INTERLEUKIN-6; JOINTS; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MALE; MIDDLE AGED; ONCOSTATIN M; OSTEOARTHRITIS; PEPTIDES; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030903094     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400614     Document Type: Article

References (48)

1. Emery P, Luqmani R: The validity of surrogate markers in rheumatic disease. Br J Rheumatol 32:3-8, 1993
2. Mallya RK, de Beer F, Berry H, Hamilton ED, Mace BE, Pepys M: Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol 9:224-228, 1982
3. Amos RS, Constable TJ, Crockson RA, Crockson AP, McConkey B: Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. BMJ 1:195-197, 1977
4. Larsen A: The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis. Scand J Rheumatol 17:123-129, 1988
5. Dawes PT, Fowler PD, Clarke S, Fisher J, Lawton A, Shadforth MF: Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiologic progression. Br J Rheumatol 25:44-49, 1986
6. Gauldie J, Richards C, Northemann W, Fey G, Baumann H: IFN|β2/BSF2/IL-6 is the monocyte-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes. Ann N Y Acad Sci 557:46-59, 1989
7. Baumann H, Richards C, Gauldie J: Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. J Immunol 139:4122-4128, 1987
8. Ganapathi MK, Schnitz D, Mackiewicz A, Samols D, Hu S, Brahenec A, Macintyre SS, Kushner I: Heterogeneous nature of the acute phase response: differential regulation of human serum amyloid A, C-reactive protein and other acute phase proteins by cytokines in Hep 3B cells. J Immunol 141:564-569, 1988
9. Ganapathi MK, May LT, Schultz D, Brabenec A, Weinstein J, Sehgal PB, Kushner I: Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines. Biochem Biophys Res Commun 157:271-277, 1988
10. Smith JW, McDonald TL: Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisolone. Clin Exp Immunol 90:293-299, 1992
11. Castell JV, Gomez-Lechon MJ, David M, Hirano T, Kishimoto T, Heinrich PC: Recombinant human interleukin-6 (IL-6/BSF-2/ HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 232:347-350, 1988
12. Moshage HJ, Roelofs HMJ, van Leewen JF, Limburg PC: The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult T human hepatocytes. Biochem Biophys Res Commun 155:112-117, 1988
13. Baumann H, Schendel P: Interleukin-11 regulates the hepatic expression of the same plasma protein genes as interleukin-6. J Biol Chem 266:20424-20427, 1991
14. Baumann H, Wong GG: Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor. J Immunol 143:1163-1167, 1989
15. Richards CD, Brown TJ, Shoyab M, Baumann H, Gauldie J: Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J Immunol 148:1731-1736, 1992
16. Kishimoto T, Taga T, Akira S: Cytokine signal transduction. Cell 76:253-262, 1994
17. Firestein GS, Alvaro-Gracia JM, Maki R: Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 144:3347-3353, 1990
18. Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M: Synovium as a source of interleukin 6 in vitro. J Clin Invest 83:585-592, 1989
19. Houssiau FA, Devogelaer J-P, van Damme J, Nagant de Deuxchaisnes C, van Snick J: Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arlhritides. Arthritis Rheum 31:784-788, 1988
20. Brozik M, Rosztoczy I, Meretey K, Balint G, Gaal M, Balogh Z, Bart M, Mituszova M, Velics V, Falus A: Interleukin-6 levels in synovial fluids of patients with different arthritides: correlation with local IgM rheumatoid factor and systemic acute phase protein production. J Immunol 19:63-68, 1992
21. Maier R, Ganu V, Lotz M: Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J Biol Chem 268:21527-21532, 1993
22. Lotz M, Moats T, Villiger PM: Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J Clin Invest 90:888-896, 1992
23. Hamilton JA, Waring PM, Filonzi EL: Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-α. J Immunol 150:1496-1502, 1993
24. Waring P, Wycherley K, Gary D, Nicola N, Metcalf D: Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J Clin Invest 90:2031-2037, 1992
25. Waring PM, Carroll GJ, Kandiah DA, Buirski G, Metcalf D: Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 36:911-915, 1993
26. Gabay C, Singwe M, Genin B, Meyer O, Mentha G, Coultre CL, Vischer T, Guerne PA: Circulating levels of IL-11 and leukemia inhibitory factor (LIF) do not significantly participate in the production of acute-phase proteins by the liver. Clin Exp Immunol 105:260-265, 1996
27. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
28. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, Howell D, Kaplan D, Koopman W, Longley S III, Mankin H, McShane DJ, Medsger T Jr, Meenan R, Mikkelsen W, Moskowitz R, Murphy W, Rothschild B, Segal M, Sokoloff L, Wolfe F: Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 29:1039-1049, 1986
29. Yamamura M, Wang XH, Ohmen JD, Uyemura K, Rea TH, Bloom BR, Modlin RL: Cytokine patterns of immunologically mediated tissue damage. J Immunol 149:1470-1475, 1992
30. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Brocmeyer H, Manolagas SC: Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91, 1992
31. Girasole G, Passed G, Jilka RL, Manolagas SC: Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest 93:1516-1524, 1994
32. Reid IR, Lowe C, Cornish J, Skinner SJM, Hilton DJ, Willson TA, Gearing DP, Martin TJ: Leukemia inhibitory factor: a novel bone-active cytokine. Endocrinology 126:1416-1420, 1990
33. Anderson KC, Morimoto C, Paul SR, Chauhan D, William D, Cochran M, Barut BA: Interleukin-11 promotes accessory cell-dependent B-cell differentiation in humans. Blood 180:2797-2804, 1992
34. Hamilton JA, Leizer T, Piccoli DS, Royston KM, Butler DM, Croatto M: Oncostatin M stimulates urokinase-type plasminogen activator activity in human synovial fibroblast. Biochem Biophys Res Commun 180:652-659, 1991
35. Arend WP, Dayer J-M: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33:305-315, 1990
36. Matsuda T, Hirano T, Nagasawa S, Kishimoto T: Identification of α2-macroglobulin as a carrier protein for IL-6. J Immunol 142:148-152, 1989
37. May LT, Viguet H, Kenney JS, Ida N, Allison AC, Sehgal PB: High levels of "complexed" interleukin-6 in human blood. J Biol Chem 267:19698-19704, 1992
38. Hough AJ: Pathology of osteoarthritis. In, Arthritis and Allied Conditions. Twelfth edition. Edited by DJ McCarty, WJ Koopman. Philadelphia, Lea & Febiger, 1993
39. Brown TJ, Lioubin MN, Marquardt H: Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes: synergistic antiproliferative activity of transform-ing growth factor β1, Interferon-γ, oncostatin M for human melanoma cells. J Immunol 139:2977-2983, 1987
40. Firestein GS, Zvaifler NJ: How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 33:768-773, 1990
41. Heinrich PC, Castell JV, Andus T: Interleukin-6 and the acute phase response. Biochem J 265:621-636, 1990
42. Nijsten MW, de Groot ER, ten Duis HJ, Klasen HJ, Hack CE, Aarden LA: Serum levels of interleukin-6 and acute phase responses (letter). Lancet 2:921, 1987
43. Lecron JC, Roblot P, Chevalier S, Morel F, Alederman E, Gombert J, Gascan H: High circulating leukemia inhibitory factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL-6 under corticosteroid therapy. Clin Exp Immunol 92:23-26, 1993
44. Banks RE, Forbes MA, Storr M, Higginson J, Thompson D, Raynes J, Illingworth JM, Perren TJ, Selby PJ, Whicher JT: The acute phase protein response in patients receiving subcutaneous IL-6. Gin Exp Immunol 102:217-223, 1995
45. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Kohler G: Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339-342, 1994
46. Mackiewicz A, Schooltink H, Heinrich PC, Rose-John S: Complex of soluble human IL-6-receptor/IL-6 up-regulales expression of acute-phase proteins. J Immunol 149:2021-2027, 1992
47. Gaillard JP, Bataille R, Brailly H, Zuber C, Yasukawa K, Attal M, Maruo N, Taga T, Kishimoto T, Klein B: Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur J Immunol 23:820-824, 1993
48. Mihara M, Moriya Y, Kishimoto T, Ohsugi Y: Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol 34:321-325, 1995